Model Integration and Configuration for Phase II-III Clinical Pharmacovigilance

Phase II-III clinical trial pharmacovigilance data originates from Clinical Study Reports (CSRs), Case Report Forms (CRFs), Serious Adverse Event

Data Characteristics

Phase II-III clinical trial pharmacovigilance data originates from Clinical Study Reports (CSRs), Case Report Forms (CRFs), Serious Adverse Event (SAE) reports, Development Safety Update Reports (DSURs), and Investigator's Brochures (IBs). This data combines structured formats (e.g., database records) and unstructured formats (e.g., clinical narrative text, medical imaging reports). Data updates frequently, especially during trials, with SAE reports requiring submission within specified timelines. Document structures are complex, containing extensive medical terminology, abbreviations, and codes. Examples include MedDRA codes for adverse event classification and WHO-DD codes for drug classification. Fields include subject demographics, medication information, adverse event descriptions, event start/end times, severity, outcome, and causality assessments.

Constraints on Model Integration and Configuration

The mixed structure of Phase II-III clinical pharmacovigilance data presents challenges for model integration. Medical terminology and abbreviations in unstructured text require models with strong semantic understanding. This necessitates incorporating specialized medical dictionaries or pre-trained models. High update frequency means models must support incremental learning or rapid retraining mechanisms to ensure timeliness. Sensitive information (e.g., subject identity) requires strict anonymization before model input. This impacts data preprocessing workflows and model input formats. The use of specialized coding systems like MedDRA requires models to understand and process these codes, or to convert them into model-recognizable representations during feature engineering. Subjective fields, such as causality assessment, demand higher accuracy and interpretability from models. This may require combining expert rules or multimodal data for assistance.

Configuration Settings

Configuration ItemRecommended ValueRationale
modelIddeepseek-v2 or qwen-maxStrong Chinese comprehension and good recognition of medical terminology.
maxContext8000 tokensAccommodates longer adverse event narratives and background information in clinical reports.
chunkSize500 charactersBalances semantic completeness with vectorization efficiency, preventing key information truncation.
overlapSize100 charactersEnsures contextual continuity between segments, reducing information loss.
vectorModeltext-embedding-v3Prioritizes general-purpose text embedding models for better generalization to medical texts.
recallThreshold0.78Ensures recall of document segments highly relevant to adverse event descriptions, filtering noise.

Common Pitfalls

  • A cannot read properties of undefined error during model testing typically indicates missing API keys or endpoint URLs in the new channel configuration, leading to model initialization failure.
  • Empty extraction of key fields (e.g., adverse event name, drug name) after document parsing may result from an excessively small chunk size, preventing the model from capturing complete semantic units, or the model lacking recognition capabilities for specific medical terminology.
  • Significant discrepancies between model-outputted adverse event attribution and human judgment may stem from insufficient or inconsistent causality annotations in the training data, preventing the model from adequately learning the judgment criteria.

Verification Steps

  • Select a batch of clinical reports containing typical adverse event descriptions. Use the model for information extraction and verify the accuracy of extracted fields such as adverse events, drugs, and subject information.
  • Test the knowledge base's recall accuracy and relevance using queries of varying complexity. Ensure recalled document segments effectively support answer generation and compare them against the set threshold.
  • Simulate new SAE report submission scenarios. Observe the model's processing speed and knowledge base update speed. Verify that incremental learning or rapid indexing update mechanisms function as expected.
  • Check if the model correctly identifies and maps professional terms, such as MedDRA codes, to corresponding concepts when processing relevant text.

The values provided are common starting points. Measure them against specific samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.